Value-based care continues to transform industry, driving need for targeted therapies, finds Frost & Sullivan's Transformational Health team
LONDON, March 1, 2017 /PRNewswire/ -- Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set for an invigorating year due to a partial realisation of major healthcare policies and initiatives, technology advancements and value-based care driving the adoption and need for consumer-centric targeted therapies. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g. China, India, Brazil) which demonstrate high growth opportunities compared developed markets (e.g., US, and Western Europe. Growing at a CAGR of 4.8 percent, the industry is likely to reach revenue of $1,731.8 billion. Current predictions and trends encouraging transformation include:
The new analysis, Healthcare Industry Outlook, 2017, which is part of Frost & Sullivan's Advanced Medical Technologies Growth Partnership Service program, explores how the global healthcare landscape is expected to evolve in 2017. It identifies key trends impacting the industry from lifesciences, medical technologies, remote patient monitoring, healthcare information technologies, care delivery and business model perspectives.
Click here (https://goo.gl/qdM4ZQ) for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive briefing with Frost & Sullivan's thought leaders.
"2017 will be a tipping point for mainstream adoption of popular digital health solutions (e.g. Wearables, Telehealth), and transition of noble technologies from research to actionable clinical applications (e.g. POCT Dx tools, AI, Robotics, and Image-guided therapies)," notes Frost & Sullivan Transformational Health Research Analyst Kamaljit Behera.
Global Healthcare Industry Outlook, 2017
K152-54
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
Contact:
Jana Schöneborn
Corporate Communications – Europe
P: +49 (0)69 77033 43
E: jana.schoeneborn@frost.com
http://ww2.frost.com
twitter: @FS_Healthcare
LinkedIn: Transform Health